Survival and Cost-Effectiveness of Trabectedin Compared to Ifosfamide Monotherapy in Advanced Soft Tissue Sarcoma Patients.

Verboom, Michiel C; Gelderblom, Hans; Kerst, J Martijn; Steeghs, Neeltje; Reyners, Anna K L; Sleijfer, Stefan; van der Graaf, Winette T A; van den Hout, Wilbert B

Verboom, Michiel C; Gelderblom, Hans; Kerst, J Martijn; Steeghs, Neeltje; Reyners, Anna K L; Sleijfer, Stefan; van der Graaf, Winette T A; van den Hout, Wilbert B.

Afiliação

Verboom MC; Department of Medical Oncology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, Netherlands.
Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, Netherlands.
Kerst JM; Department of Medical Oncology and Clinical Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, P.O. Box 90203, 1006 BE Amsterdam, Netherlands.
Steeghs N; Department of Medical Oncology and Clinical Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, P.O. Box 90203, 1006 BE Amsterdam, Netherlands.
Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, P.O. Box 30001, 9700 RB Groningen, Netherlands.
Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, P.O. Box 5201, 3008 AE Rotterdam, Netherlands.
van der Graaf WTA; Department of Medical Oncology, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, Netherlands.
van den Hout WB; Department of Medical Decision Making, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, Netherlands.

Sarcoma ; 2019: 3234205, 2019.

Article em En | MEDLINE | ID: mdl-31281207

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Temas: ECOS / Financiamentos_gastos Bases de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Aspecto: Patient_preference Idioma: En Revista: Sarcoma Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google